Yates A D, Feeney J, Donald A S, Watkins W M
Carbohydr Res. 1984 Jul 15;130:251-60. doi: 10.1016/0008-6215(84)85283-0.
The B gene-specified alpha-D-(1----3)-galactosyltransferase, isolated from the serum of a blood-group B individual, was used to catalyse the transfer of N-acetyl-D-galactosamine from UDP-N-acetyl-D-galactosamine to the blood-group H-active trisaccharide 2'-fucosyllactose. The biosynthetic product had blood-group A activity and its structure was confirmed as alpha-D-GalpNAc-(1----3)-[alpha-L-Fucp-(1----2)]-beta-D-Galp-(1--- -4)-D-Glc by methylation analysis and high-resolution 1H-n.m.r. spectroscopy. This tetrasaccharide was structurally and serologically identical with that made from the same donor and acceptor substrates when the blood-group A gene-specified alpha-D-(1----3)-N-acetylgalactosaminyltransferase was used as the enzyme source. The enzyme encoded by the B gene at the blood group ABO locus thus has overlapping donor substrate specificity with the enzyme encoded by the allelic A gene, and this property confers upon the B gene-specified alpha-D-1----3)-galactosyltransferase the potential to synthesise blood-group A-active structures.
从B血型个体血清中分离出的B基因特异性α-D-(1→3)-半乳糖基转移酶,用于催化将N-乙酰-D-半乳糖胺从UDP-N-乙酰-D-半乳糖胺转移至血型H活性三糖2'-岩藻糖基乳糖。生物合成产物具有A型血型活性,其结构经甲基化分析和高分辨率1H-核磁共振光谱确认为α-D-半乳糖胺基-(1→3)-[α-L-岩藻糖基-(1→2)]-β-D-半乳糖基-(1→4)-D-葡萄糖。当使用血型A基因特异性α-D-(1→3)-N-乙酰半乳糖胺基转移酶作为酶源时,该四糖在结构和血清学上与由相同供体和受体底物生成的四糖相同。因此,血型ABO位点的B基因编码的酶与等位基因A基因编码的酶具有重叠的供体底物特异性,并且这一特性赋予B基因特异性α-D-(1→3)-半乳糖基转移酶合成血型A活性结构的潜力。